Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasminogen activator inhibitor type 1 (PAI1) and platelet glycoprotein IIIa (PGIIIa) polymorphisms in Black South Africans with pre-eclampsia.

Acta obstetricia et gynecologica Scandinavica - 1 Apr 2003

Pegoraro Rosemary J, Hira Bavna, Rom Lee, Moodley Jack

Abstract excerpt

BACKGROUND: Association of fibrin abnormalities with pre-eclampsia prompted this study to examine whether polymorphisms in the plasminogen activator inhibitor Type 1 and platelet glycoprotein IIIa genes constitute risk factors for this condition. METHODS: A group of 151 Black Zulu-speaking pre-eclamptics was examined for 4G/5G plasminogen activator inhibitor Type 1 and PlA1/A2 platelet glycoprotein IIIa...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Black People
Share to Gene Frequency

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Integrin beta3

Share to Plasminogen Activator Inhibitor 1

Share to Pre-Eclampsia

Share to Pregnancy

Share to Risk Factors

Share to South Africa

Source

Identifiers

PMID: 12716314
DOI: 10.1034/j.1600-0412.2003.00085.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasminogen activator inhibitor type 1 (PAI1) and platelet glycoprotein IIIa (PGIIIa) polymorphisms in Black South Africans with pre-eclampsia.PMID 12716314Read ↗

Association of plasminogen activator inhibitor-type 1 (-675 4G/5G) polymorphism with pre-eclampsia: systematic review.Semantic proximity Read ↗

Candidate Gene, Genome-Wide Association and Bioinformatic Studies in Pre-eclampsia: a Review.Semantic proximity Read ↗

Absence of Factor V Leiden, thrombomodulin and prothrombin gene variants in Black South African women with pre-eclampsia and eclampsia.Semantic proximity Read ↗

Association of single nucleotide polymorphisms (4G/5G) of plasminogen activator inhibitor-1 and the risk factors for placenta-related obstetric complications.Semantic proximity Read ↗

In black South Africans from rural and urban communities, the 4G/5G PAI-1 polymorphism influences PAI-1 activity, but not plasma clot lysis time.Semantic proximity Read ↗

Hypertension-related gene polymorphisms in pre-eclampsia, eclampsia and gestational hypertension in Black South African women.Semantic proximity Read ↗

Maternal variants within the apolipoprotein L1 gene are associated with preeclampsia in a South African cohort of African ancestry.Semantic proximity Read ↗

The PAI-1 4G/5G polymorphism is not associated with an increased risk of adverse pregnancy outcome in asymptomatic nulliparous women.Semantic proximity Read ↗

Genetic hypofibrinolysis in complicated pregnancies.Semantic proximity Read ↗

Plasminogen activator inhibitor-1 polymorphism in women with pre-eclampsia.Semantic proximity Read ↗

Association of gene polymorphisms of four components of renin-angiotensin-aldosterone system and preeclampsia in South African black women.Semantic proximity Read ↗

Maternal and fetal single nucleotide polymorphisms in the epoxide hydrolase and gluthatione S-transferase P1 genes are not associated with pre-eclampsia in the Coloured population of the Western Cape, South Africa.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.